Antisense strategies and non-viral gene therapy for cancer

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.3, 2002-03, pp. : 379-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy

Current Medicinal Chemistry, Vol. 22, Iss. 35, 2015-11 ,pp. : 4118-4136

Bentham Science Publishers

Access to resources Recommend Favorite

Non-viral Delivery Systems for Breast Cancer Gene Therapy

Current Gene Therapy, Vol. 17, Iss. 2, 2017-07 ,pp. : 147-153

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphonolipids as non-viral vectors for gene therapy

By Floch V. Le Bolc'h G. Gable-Guillaume C. Le Bris N. Yaouanc J.-J. des Abbayes H. Ferec C. Clement J.-C.

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 923-934

Elsevier

Access to resources Recommend Favorite

Non-Viral Delivery of RNA Interference Targeting Cancer Cells in Cancer Gene Therapy

Current Gene Therapy, Vol. 12, Iss. 4, 2012-01 ,pp. : 275-284

Bentham Science Publishers

Access to resources Recommend Favorite

Non-viral methods for gene transfer towards osteosarcoma therapy

By Dass Crispin Choong Peter

Journal of Drug Targeting, Vol. 15, Iss. 3, 2007-04 ,pp. : 184-189

Informa Healthcare

Access to resources Recommend Favorite